Correlation Between MedPacto and Prestige Biologics

Can any of the company-specific risk be diversified away by investing in both MedPacto and Prestige Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedPacto and Prestige Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MedPacto and Prestige Biologics Co, you can compare the effects of market volatilities on MedPacto and Prestige Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedPacto with a short position of Prestige Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedPacto and Prestige Biologics.

Diversification Opportunities for MedPacto and Prestige Biologics

0.29

Correlation Coefficient

MedPacto  Prestige Biologics

Modest diversification

The 3 months correlation between MedPacto and Prestige is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding MedPacto and Prestige Biologics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Biologics and MedPacto is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedPacto are associated (or correlated) with Prestige Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Biologics has no effect on the direction of MedPacto i.e., MedPacto and Prestige Biologics go up and down completely randomly.

Pair Corralation between MedPacto and Prestige Biologics

Assuming the 90 days trading horizon MedPacto is expected to under-perform the Prestige Biologics. In addition to that, MedPacto is 1.0 times more volatile than Prestige Biologics Co. It trades about -0.16 of its total potential returns per unit of risk. Prestige Biologics Co is currently generating about 0.01 per unit of volatility. If you would invest  446,000  in Prestige Biologics Co on December 7, 2024 and sell it today you would lose (19,000) from holding Prestige Biologics Co or give up 4.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

MedPacto  vs.  Prestige Biologics Co

MedPacto

Risk-Adjusted Performance

Very Weak

Over the last 90 days MedPacto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Prestige Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Prestige Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Prestige Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with MedPacto and Prestige Biologics

The main advantage of trading using opposite MedPacto and Prestige Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedPacto position performs unexpectedly, Prestige Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Biologics will offset losses from the drop in Prestige Biologics' long position.

The idea behind MedPacto and Prestige Biologics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.